Similarly, the TRAF5 high-expression group showed improved PFS (P = 0.022), DFS (P = 0.00063), and DSS (P = 0.0085) in TCGA-BLCA and better prognosis in GSE13507 (P = 0.04), GSE19423 (P = 0.043), GSE48075(P = 0.033), and GSE154261 (P = 0.013). The gene discussed is TRAF5; the disease is bladder transitional cell carcinoma.